-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, the company's holding subsidiary Henan Zhongshuai Pharmaceutical Technology Co., Ltd. received the “Drug Registration Certificate” for acetazolamide sustained-release capsules issued by the State Drug Administration. This drug is the first drug approved in China to prevent or ameliorate acute mountain sickness. Obtaining the “Drug Registration Certificate” this time is considered to have passed the consistency evaluation.

Zhitongcaijing·08/11/2026 09:41:09
Listen to the news
Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, the company's holding subsidiary Henan Zhongshuai Pharmaceutical Technology Co., Ltd. received the “Drug Registration Certificate” for acetazolamide sustained-release capsules issued by the State Drug Administration. This drug is the first drug approved in China to prevent or ameliorate acute mountain sickness. Obtaining the “Drug Registration Certificate” this time is considered to have passed the consistency evaluation.